To accelerate research into dysferlinopathy and related muscle diseases and to support the development of effective treatments by funding research, sharing resources, and connecting researchers, clinicians and patients.
$0
$0
$0
$0
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
2026
Source: IRS Form 990-PF, fiscal year 2026.
No grant history is available for this foundation yet.
Current and upcoming funding from Dr Rajeev and Seema Jain Foundation that your nonprofit may be able to apply for.
Who can apply: Open to neurology clinics in the US participating in the clinic support program; individuals with LGMD can request support for their clinic. This is primarily a support/resources program rather than a cash grant.
Who can apply: Projects must have direct application to dysferlinopathies (LGMD2B, LGMDR2, Miyoshi Myopathy 1). Proposals are reviewed in-house by the scientific advisory board. The site references new submissions and renewals.
Deadline: Rolling basis; typically response within 4-6 weeks.
Who can apply: Research projects aligned with the foundation's CNNM2 mission; the scraped content shows direct contact emails for research funding inquiries but does not provide public eligibility rules.
Who can apply: Projects must have application to dysferlinopathies (LGMD2B, LGMDR2, or Miyoshi Myopathy 1). Proposals are reviewed in-house by the Jain Foundation Scientific Advisory Board. The site indicates the foundation funds research projects and other mission-critical programs; specific applicant eligibility details are not fully listed on the provided pages.
Deadline: Rolling basis; typically response within 4-6 weeks.
Who can apply: Project must have application to dysferlinopathies (LGMD2B, LGMDR2, or Miyoshi Myopathy); proposals are reviewed in-house by the scientific advisory board.
Deadline: Rolling basis
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.